Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic abnormalities in Waldenström's macroglobulinemia.

Clinical lymphoma & myeloma - 1 Mar 2009

Adamia Sophia, Pilarski Patrick M, Belch Andrew R, Pilarski Linda M

Abstract excerpt

The genetic factors that lead to WM are mostly unknown but are likely to involve inherited polymorphisms that might be markers of increased risk for developing WM, and somatic mutations that might be acquired during the events leading to oncogenesis and cancer progression. By intensive sequencing of the hyaluronan synthase 1 (HAS1) gene in malignant and normal cells from patients with WM, we have identified both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Genetic Variation
Share to Glucuronosyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Waldenstrom Macroglobulinemia

Source

Identifiers

PMID: 19362966
DOI: 10.3816/CLM.2009.n.006

Genes

HAS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic abnormalities in Waldenström's macroglobulinemia.PMID 19362966Read ↗

Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.Semantic proximity Read ↗

Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia.Semantic proximity Read ↗

Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.Semantic proximity Read ↗

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.Semantic proximity Read ↗

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.Semantic proximity Read ↗

Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia.Semantic proximity Read ↗

Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.Semantic proximity Read ↗

The Evolution and Subtypes of Waldenstrom Macroglobulinemia: Findings from a Multi-omic Analysis of 249 Treatment Naive MYD88L265P Mutated Patients.Semantic proximity Read ↗

Clinical application of genomics in Waldenström macroglobulinemia.Semantic proximity Read ↗

Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myelomaSemantic proximity Read ↗

Genomic Landscape of Waldenström Macroglobulinemia.Semantic proximity Read ↗

Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.